First Trust Advisors’s Acorda Therapeutics ACOR Stock Holding History

First Trust Advisors’s Portfolio ACOR Stock Details ACOR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-198	Closed	-$315K	–	2531
2019 Q1	$315K	Buy	+198	New	+$357K	﹤0.01%	2258
2018 Q4	–	Sell	-1,454	Closed	-$3.43M	–	2504
2018 Q3	$3.43M	Buy	1,454 +641	+79%	+$1.98M	0.01%	1352
2018 Q2	$2.8M	Buy	+813	New	+$2.49M	0.01%	1433
2017 Q2	–	Sell	-148	Closed	-$372K	–	2471
2017 Q1	$372K	Buy	+148	New	+$426K	﹤0.01%	2164
2016 Q3	–	Sell	-105	Closed	-$321K	–	2405
2016 Q2	$321K	Sell	105 -312	-75%	-$1.01M	﹤0.01%	2076
2016 Q1	$1.32M	Buy	+417	New	+$1.73M	﹤0.01%	1531
2015 Q2	–	Sell	-484	Closed	-$1.93M	–	2306
2015 Q1	$1.93M	Buy	484 +361	+293%	+$1.65M	0.01%	1496
2014 Q4	$603K	Buy	+123	New	+$528K	﹤0.01%	1927
2014 Q3	–	Sell	-216	Closed	-$875K	–	2315
2014 Q2	$875K	Buy	+216	New	+$881K	﹤0.01%	1738
2013 Q4	–	Sell	-128	Closed	-$524K	–	2263
2013 Q3	$524K	Buy	128 +20	+19%	+$86.1K	﹤0.01%	1884
2013 Q2	$427K	Buy	+108	New	+$445K	﹤0.01%	1880

Other funds holding ACOR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

First Trust Advisors's ACOR Position: Q2 2019 in Review

First Trust Advisors sold out of Acorda Therapeutics (ACOR) in Q2 2019, closing a stake of 198 shares — an estimated $315K sold.

First Trust Advisors first reported a position in ACOR in Q2 2013 and held it in 11 quarters. The position peaked at $3.43M in Q3 2018. 163 funds tracked by Wall St. Rank hold ACOR as of Q2 2019.

First Trust Advisors reported no remaining Acorda Therapeutics position as of Q2 2019 after selling out during the quarter.
First Trust Advisors sold 198 Acorda Therapeutics shares in Q2 2019, an estimated $315K.
First Trust Advisors first reported a position in Acorda Therapeutics in Q2 2013 and held it in 11 quarters.
First Trust Advisors's Acorda Therapeutics position peaked at $3.43M in Q3 2018.
163 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q2 2019.

Based on First Trust Advisors's 13F filing for Q2 2019, filed 30 Jul 2019.